BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 17974989)

  • 21. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
    Chen D; Cui QC; Yang H; Barrea RA; Sarkar FH; Sheng S; Yan B; Reddy GP; Dou QP
    Cancer Res; 2007 Feb; 67(4):1636-44. PubMed ID: 17308104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
    Mukherjee B; Mayer D
    Int J Oncol; 2008 Sep; 33(3):623-9. PubMed ID: 18695894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PKD, PKD2, and p38 MAPK mediate Hsp27 serine-82 phosphorylation induced by neurotensin in pancreatic cancer PANC-1 cells.
    Yuan J; Rozengurt E
    J Cell Biochem; 2008 Feb; 103(2):648-62. PubMed ID: 17570131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors.
    Snoek R; Cheng H; Margiotti K; Wafa LA; Wong CA; Wong EC; Fazli L; Nelson CC; Gleave ME; Rennie PS
    Clin Cancer Res; 2009 Jan; 15(1):39-47. PubMed ID: 19118031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperthermia-induced proteasome inhibition and loss of androgen receptor expression in human prostate cancer cells.
    Pajonk F; van Ophoven A; McBride WH
    Cancer Res; 2005 Jun; 65(11):4836-43. PubMed ID: 15930304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-4 in patients with prostate cancer.
    Takeshi U; Sadar MD; Suzuki H; Akakura K; Sakamoto S; Shimbo M; Suyama T; Imamoto T; Komiya A; Yukio N; Ichikawa T
    Anticancer Res; 2005; 25(6C):4595-8. PubMed ID: 16334148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer.
    Kang HY; Huang HY; Hsieh CY; Li CF; Shyr CR; Tsai MY; Chang C; Chuang YC; Huang KE
    J Bone Miner Res; 2009 Jul; 24(7):1180-93. PubMed ID: 19257827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interrogating androgen receptor function in recurrent prostate cancer.
    Zhang L; Johnson M; Le KH; Sato M; Ilagan R; Iyer M; Gambhir SS; Wu L; Carey M
    Cancer Res; 2003 Aug; 63(15):4552-60. PubMed ID: 12907631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha.
    Buchanan G; Ricciardelli C; Harris JM; Prescott J; Yu ZC; Jia L; Butler LM; Marshall VR; Scher HI; Gerald WL; Coetzee GA; Tilley WD
    Cancer Res; 2007 Oct; 67(20):10087-96. PubMed ID: 17942943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of nucleophosmin/B23 on DNA binding and transcriptional activity of the androgen receptor in prostate cancer cell.
    Léotoing L; Meunier L; Manin M; Mauduit C; Decaussin M; Verrijdt G; Claessens F; Benahmed M; Veyssière G; Morel L; Beaudoin C
    Oncogene; 2008 May; 27(20):2858-67. PubMed ID: 18037965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the hsp90 inhibitor geldanamycin on androgen response of prostate cancer under hypoxic conditions.
    Suzuki Y; Kondo Y; Hara S; Kimata R; Nishimura T
    Int J Urol; 2010 Mar; 17(3):281-5. PubMed ID: 20409220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
    Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME
    Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
    Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia increases androgen receptor activity in prostate cancer cells.
    Park SY; Kim YJ; Gao AC; Mohler JL; Onate SA; Hidalgo AA; Ip C; Park EM; Yoon SY; Park YM
    Cancer Res; 2006 May; 66(10):5121-9. PubMed ID: 16707435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells.
    Gao J; Isaacs JT
    Cancer Res; 1998 Aug; 58(15):3299-306. PubMed ID: 9699659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells.
    Ma AH; Xia L; Desai SJ; Boucher DL; Guan Y; Shih HM; Shi XB; deVere White RW; Chen HW; Tepper CG; Kung HJ
    Cancer Res; 2006 Sep; 66(17):8439-47. PubMed ID: 16951154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells.
    Hsieh CL; Cai C; Giwa A; Bivins A; Chen SY; Sabry D; Govardhan K; Shemshedini L
    J Mol Endocrinol; 2008 Jul; 41(1):13-23. PubMed ID: 18469090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential phosphoprotein levels and pathway analysis identify the transition mechanism of LNCaP cells into androgen-independent cells.
    Wang HQ; Yang B; Xu CL; Wang LH; Zhang YX; Xu B; Ji JT; Sun YH
    Prostate; 2010 Apr; 70(5):508-17. PubMed ID: 19937597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells.
    Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J
    J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.